Pharmaceutical composition
    1.
    发明申请
    Pharmaceutical composition 有权
    药物组成

    公开(公告)号:US20020172649A1

    公开(公告)日:2002-11-21

    申请号:US10124197

    申请日:2002-04-16

    IPC分类号: A61K007/06

    摘要: A pharmaceutical composition for topical administration, including, as the pharmaceutically active component, at least 5% by weight, based on the total weight of the composition of a piperidinopyrimidine derivative or a pharmaceutically acceptable salt thereof; an acid in an amount to completely solubilise the piperidinopyrimidine derivative or a pharmaceutically acceptable salt thereof; a solvent composition including at least two of water, a lower alcohol and a co-solvent selected from one or more of the group consisting of aromatic and polyhydric alcohols; wherein when the co-solvent includes propylene glycol, it is present in an amount of less than approximately 10% by weight.

    摘要翻译: 用于局部给药的药物组合物,包括作为药物活性成分的至少5重量%,基于组合物的总重量为哌啶并嘧啶衍生物或其药学上可接受的盐; 一定量使得哌啶并嘧啶衍生物或其药学上可接受的盐完全溶解的酸; 包含水,低级醇和选自芳族和多元醇中的一种或多种的共溶剂中的至少两种的溶剂组合物; 其中当共溶剂包括丙二醇时,其存在量小于约10重量%。